Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsuyoshi Muta

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Hematology|July 24, 2013
Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myelomaToshihiro Miyamoto, Goichi Yoshimoto, Tomohiko Kamimura, et al.
Acta Haematologica|January 18, 2018
Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in JapanTsuyoshi Muta, Toshihiro Miyamoto, Tomohiko Kamimura, et al.
Annals of Hematology|October 20, 2019
Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantationShuro Yoshida, Yuju Ohno, Koji Nagafuji, et al.
British Journal of Haematology|March 25, 2017
Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinibMariko Minami, Takeshi Arita, Hiromi Iwasaki, et al.
Biological & Pharmaceutical Bulletin|May 8, 2013
Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantationMayako Uchida, Hiroaki Ikesue, Toshihiro Miyamoto, et al.
Cancer Science|April 22, 2020
Tyrosine kinase inhibitors induce alternative spliced BCR-ABL<sup>Ins35bp</sup> variant via inhibition of RNA polymerase II on genomic BCR-ABLJunichiro Yuda, Jun Odawara, Mariko Minami, et al.
International Journal of Hematology|September 26, 2018
Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantationSatoshi Yamasaki, Goichi Yoshimoto, Kentaro Kohno, et al.
International Journal of Hematology|June 15, 2014
Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patientsShuichiro Takashima, Toshihiro Miyamoto, Masanori Kadowaki, et al.
Biological & Pharmaceutical Bulletin|February 9, 2013
Decrease in venous irritation by adjusting the concentration of injected bendamustineHiroyuki Watanabe, Hiroaki Ikesue, Tomoko Tsujikawa, et al.
Pharmacotherapy|May 29, 2013
Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantationMayako Uchida, Koji Kato, Hiroaki Ikesue, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Hematology|July 24, 2013
Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myelomaToshihiro Miyamoto, Goichi Yoshimoto, Tomohiko Kamimura, et al.
Acta Haematologica|January 18, 2018
Significance of Salvage Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma: A Nationwide Retrospective Study in JapanTsuyoshi Muta, Toshihiro Miyamoto, Tomohiko Kamimura, et al.
Annals of Hematology|October 20, 2019
Comparison of calcineurin inhibitors in combination with conventional methotrexate, reduced methotrexate, or mycophenolate mofetil for prophylaxis of graft-versus-host disease after umbilical cord blood transplantationShuro Yoshida, Yuju Ohno, Koji Nagafuji, et al.
British Journal of Haematology|March 25, 2017
Comparative analysis of pulmonary hypertension in patients treated with imatinib, nilotinib and dasatinibMariko Minami, Takeshi Arita, Hiromi Iwasaki, et al.
Biological & Pharmaceutical Bulletin|May 8, 2013
Effectiveness and safety of antiemetic aprepitant in Japanese patients receiving high-dose chemotherapy prior to autologous hematopoietic stem cell transplantationMayako Uchida, Hiroaki Ikesue, Toshihiro Miyamoto, et al.
Cancer Science|April 22, 2020
Tyrosine kinase inhibitors induce alternative spliced BCR-ABL<sup>Ins35bp</sup> variant via inhibition of RNA polymerase II on genomic BCR-ABLJunichiro Yuda, Jun Odawara, Mariko Minami, et al.
International Journal of Hematology|September 26, 2018
Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantationSatoshi Yamasaki, Goichi Yoshimoto, Kentaro Kohno, et al.
International Journal of Hematology|June 15, 2014
Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patientsShuichiro Takashima, Toshihiro Miyamoto, Masanori Kadowaki, et al.
Biological & Pharmaceutical Bulletin|February 9, 2013
Decrease in venous irritation by adjusting the concentration of injected bendamustineHiroyuki Watanabe, Hiroaki Ikesue, Tomoko Tsujikawa, et al.
Pharmacotherapy|May 29, 2013
Efficacy and safety of aprepitant in allogeneic hematopoietic stem cell transplantationMayako Uchida, Koji Kato, Hiroaki Ikesue, et al.
Pageof 6